All Sauce from Weekly Sauce:

Psilocybin could help people suffering from a mental health problem that can lead to eating disorders, a new study suggests. Psilocybin, the active chemical in “magic” mushrooms, significantly reduced symptoms in people with body dysmorphic disorder (BDD), researchers reported Sept. 24 in the journal Psychedelics. BDD causes an obsessive preoccupation with perceived flaws in one’s…  read on >  read on >

Surrogate moms have a higher risk of pregnancy complications than other pregnant women, a new study finds. About 8% of surrogate mothers developed a severe complication like high blood pressure or serious bleeding during delivery, Canadian researchers report. By comparison, only 2% of women who conceive naturally and 4% of women who conceive via IVF…  read on >  read on >

Kids born during the first year of the COVID-19 pandemic appear to have no higher risk of autism, even if they were exposed to COVID in the womb, a new study finds. The study offers reassurance to doctors and parents who’ve been worried about the developmental health of children born during the pandemic, said senior…  read on >  read on >

If global warming is left largely unchecked, the number of Americans who succumb to extreme heat will triple by mid-century, new projections estimate. These deaths could affect poor and minority Americans much more than the white and better-off, according to a team led by Dr. Sameed Khatana of the University of Pennsylvania. Rising temperatures will…  read on >  read on >

Psilocybin, the active ingredient in magic mushrooms, appears to ease depression symptoms at least as well as one of the most commonly used antidepressants, a new clinical trial shows. Patients showed significant improvement in their depressive symptoms after taking either a single dose of psilocybin or a six-week course of the SSRI antidepressant escitalopram (Lexapro),…  read on >  read on >